Method for inactivation and direct RT-qPCR of SARS-CoV-2

NewsGuard 100/100 Score

Real-time polymerase chain reaction reverse transcription (RT-qPCR) has been described as the gold standard for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection. While the process was not originally intended for diagnostic purposes, the necessity of the situation led to optimization and has resulted in several very reliable procedures to detect infection.

Study: Direct lysis RT-qPCR of SARS-CoV-2 in cell culture supernatant allows for fast and accurate quantification of virus, opening a vast array of applications. Image Credit: Corona Borealis Studio/ShutterstockStudy: Direct lysis RT-qPCR of SARS-CoV-2 in cell culture supernatant allows for fast and accurate quantification of virus, opening a vast array of applications. Image Credit: Corona Borealis Studio/Shutterstock

Researchers from the University of Edinburgh have been exploring ways to optimize this process further, allowing RT-qPCR to work more efficiently by eliminating one of the key steps.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

A preprint version of the study is available on the bioRxiv* server while the article undergoes peer review.

The study

The researchers began using 1-Step-RTqPCR with fluorescent dye detection, which is currently the most cost-effective method. Primer pairs widely used by the Centers for Disease Control (CDC) and German Center for Infection Research (DZIF) to detect SARS-CoV-2 were also selected for optimization.

First, the manufacturer's standard protocol was tested, following basic procedures and recommendations. Every primer pair tested showed around a 5-fold increase in sensitivity, with similar increases in efficiency. Unfortunately, using the standard conditions with CDC N1, DZIF N, and RdRp consistently led to the formation of primer dimers. Increasing the concentrations of N2 reduced the formation of primer dimers but did not eliminate the formation of these dimers completely.

The DZIF N primers also formed larger products than expected, and sequencing revealed circularization or multiplication of a section of the product. An increase in annealing temperature did not reduce this. The DZIF N primer's efficiency did not rise above 78.24%, the DZIF RdRp above 89.61%. The CDC N3 primer performed the best at 93.14%.

Heat lysis was first tested to release viral RNA from the virus production medium (viral culture supernatant, or VPM). Unfortunately, the release of vRNA was limited, roughly corresponding to a 1000-fold loss in sensitivity.

Following this, the researchers attempted to use lysis buffers instead, basing all buffers on a 150mM NaCl, 10mM Tris-Hcl (7.5pH) solution supplemented with lysis detergents including Triton X-100, IGEPAL-620, or Tween-20. All of these were also supplemented with RNasin – an RNA inhibitor. Proteinase K treatment was also added to assess whether it could improve vRNA release.

All the lysis buffers showed similar sensitivities, but the Tween and Triton buffers impaired the qPCR reaction. When the detergent lysis buffers were tested with heat and proteinase K for vRNA, an increase by 1.22-1.37Cts was observed. This increase was higher for 10% Triton X-100, where proteinase K digest led to a loss of 5.86Ct. The researchers decided to continue with the IGEPAL-630 buffer for further optimization, as it has similar sensitivity levels to the other buffers at lower concentrations.

Trying different concentrations of the IGEPAL-630 buffer showed efficiencies decrease at higher concentrations, but the lowest concentration, 2.5%, showed complete inactivation in cellular supernatants. No significant decrease in sensitivity was observed for the RT-PCR reaction at this concentration, but efficiency was impacted.

The researchers performed further experiments to investigate why direct lysis RPM RT-qPCR sensitivities were lower than those in extracted vRNA. They prepared 10-fold dilution series of RNA templates. Only a slight loss of efficiency could be observed across the dilution curve, and Cts were increased by an average of 8.75 cycles across all concentrations in samples involving media. Incubation in IGEPAL-630 buffer or media also increases Ct, rising if samples were incubated in both.

Addition of RNasin rescued the decrease in sensitivity this caused. Further investigation revealed the inhibition of the PCR only occurred in samples incubated in 'spent' media, not fresh media. Betaine is known to improve PCR amplification by relaxing secondary structures, but when added, it decreased the efficiency significantly or decreased the signal at lower concentrations. Sensitivity was not impacted. Increased primer concentration also failed to improve sensitivity.

Finally, the scientists tested the effect of increased amounts of lyase on the reaction to find that this significantly decreased efficiency and sensitivity. In response, they tried diluting the lysate in the reaction with NF-H2O. Lowering the concentration of lysate from VPM significantly improved sensitivity and accuracy compared to vRNA at similar amounts showed no significant difference.

Conclusion

The authors highlight that the direct lysis protocol they have developed makes a one-step RT-qPCR from cell culture supernatant possible, achieving similar results to those seen using more traditional methods that require vRNA purification. This works well with SARS-CoV-2 and could help both testing and research laboratories worldwide produce results quicker, helping to end the pandemic that has lasted over two years.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:

Article Revisions

  • May 8 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Sam Hancock

Written by

Sam Hancock

Sam completed his MSci in Genetics at the University of Nottingham in 2019, fuelled initially by an interest in genetic ageing. As part of his degree, he also investigated the role of rnh genes in originless replication in archaea.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Hancock, Sam. (2023, May 08). Method for inactivation and direct RT-qPCR of SARS-CoV-2. News-Medical. Retrieved on April 25, 2024 from https://www.news-medical.net/news/20211207/Method-for-inactivation-and-direct-RT-qPCR-of-SARS-CoV-2.aspx.

  • MLA

    Hancock, Sam. "Method for inactivation and direct RT-qPCR of SARS-CoV-2". News-Medical. 25 April 2024. <https://www.news-medical.net/news/20211207/Method-for-inactivation-and-direct-RT-qPCR-of-SARS-CoV-2.aspx>.

  • Chicago

    Hancock, Sam. "Method for inactivation and direct RT-qPCR of SARS-CoV-2". News-Medical. https://www.news-medical.net/news/20211207/Method-for-inactivation-and-direct-RT-qPCR-of-SARS-CoV-2.aspx. (accessed April 25, 2024).

  • Harvard

    Hancock, Sam. 2023. Method for inactivation and direct RT-qPCR of SARS-CoV-2. News-Medical, viewed 25 April 2024, https://www.news-medical.net/news/20211207/Method-for-inactivation-and-direct-RT-qPCR-of-SARS-CoV-2.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Oregon study finds no clear link between mRNA vaccines and sudden cardiac deaths in young people